Follow Embla Medical for company highlights and financial results.
As of today, April 8th, Embla Medical is traded under the ticker EMBLA on the Nasdaq Copenhagen Stock Exchange 🎉 https://lnkd.in/entG6msc
Skip to main content
Follow Embla Medical for company highlights and financial results.
As of today, April 8th, Embla Medical is traded under the ticker EMBLA on the Nasdaq Copenhagen Stock Exchange 🎉 https://lnkd.in/entG6msc
To view or add a comment, sign in
Today we announced that we will be changing our Nasdaq stock ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, aTyr’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.” As we advance our lead therapeutic candidate, efzofitimod, through a pivotal Phase 3 study in pulmonary sarcoidosis and prepare for potential commercialization, the “ATYR” ticker symbol is a strong reflection of our corporate identity and serves to clarify and enhance our visibility across a broad range of stakeholders. No action is required by existing stockholders with respect to the ticker symbol change. Read more at: https://bit.ly/4c0CueI
To view or add a comment, sign in
#PressRelease - #SharpsTechnology #STSS announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors. The company issued 4,418,521 shares of common stock and pre-funded warrants to acquire common stock in a registered direct offering. The purchase price of each share was $0.64. The purchase price for the pre-funded warrants was identical to the purchase price for shares, less the exercise price of $0.001 per share. https://lnkd.in/gHdxAS7y #MedicalDeviceNetwork #MedDeviceCommunity #HealthTechNetwork #MedTechIndustry #HealthcareDevices #MedDeviceInnovation #MedDeviceExperts #MedDeviceSolutions #MedDeviceInsightscompany #HealthcareInventions
To view or add a comment, sign in
Thousand Oaks-based Atara Biotherapeutics announced June 17 that it will be undergoing a 1-for-25 reverse stock split which will become effective at 12:01 a.m. June 20. A reverse stock split consolidates the number of existing shares of stock into fewer, higher-priced shares. For example, Atara shares closed at 42 cents per share on June 16, dropping 16% over the course of the trading day. If the reverse stock split occurred at 12:01 after that closing price, shares would be worth roughly $10.50 per share. https://lnkd.in/gZFC-gdE
To view or add a comment, sign in
$SCNI - Do not drop your Scinai Immunotherapeuti shares yet. Upcoming quarterly report is on 15th of April 2024: About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scinai Immunotherapeutics recorded a loss per share of 4.36. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 25th of November 2022. https://lnkd.in/gH-FhHQK #stocks #stocktwits #thematic_portfolio
To view or add a comment, sign in
#TH - Theratechnologies Announces 1for4 Reverse Stock Split - Issued and outstanding common shares to be consolidated on the basis of 1 post-consolidation share for each 4 pre-consolidation shares issued and outstanding, to regain compliance with NASDAQ listing requirements This news release constitutes a “designated news release” fo... July 20, 2023 at 07:00AM #StockMarket #MWN
To view or add a comment, sign in
$LPTX - Upcoming quarterly report will be on 22nd of March 2024.: About 33.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.14. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Leap Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.75. The entity recorded a loss per share of 4.83. The firm had not issued any dividends in recent years. Leap Therapeutics had 1:10 split on the 21st of June 2023. https://lnkd.in/gKPhX_cg #stocks #stocktwits #thematic_portfolio
To view or add a comment, sign in
Capital Raising & Exit Specialist | IPO, M&A, PE/VC | Head of Primary Markets, Americas @ LSEG | Advisory Board Chair @ FE International
Strong UK capacity for incumbent shareholder selldowns: #NYSE / #LSE listed Haleon (3x more liquid in London vs NYC = narrative violation) saw Pfizer sell down $3.5bn of stock in an upsized offering at a 4% discount along with a concurrent buyback reducing its stake from 32% to 23%. Perhaps unsurprisingly given the liquidity comment above, 75% of the deal was placed as London listed ordinary shares vs American depositary shares. Interestingly, this deal counts as the LARGEST FOLLOW-ON DEAL IN US MARKETS since September 2021! (ironic as most of it went to UK / Europe). https://lnkd.in/eaYSvUEj And Vitruvian Partners raised nearly $40m via an upsized sale of nearly 4% of Trustpilot stock at a 4% discount: https://lnkd.in/efc-wayz cc London Stock Exchange, LSEG (London Stock Exchange Group), NYSE #markets #equities #ipo #venturecapital #privateequity
To view or add a comment, sign in
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Why Lenz picked a reverse merger instead of an IPO: Q&A >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical
To view or add a comment, sign in
Thoughts on this? >> Why Lenz picked a reverse merger instead of an IPO: Q&A >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #pharma #biotech #healthcare
To view or add a comment, sign in
Leadership; Content; Strategy and Operations; Senior Financial Analyst; Senior Research Associate; ESG
Despite the initial sluggishness, the IPO market has shown robust performance so far in 2023. The Renaissance IPO Index has risen by 31% year-to-date, outpacing the 12% increase in the S&P 500. This indicates a significant investor interest in IPOs, even amid the current market volatility. #ipos #niloofermarketviews #nilooferfinancialnews #ustsocks #nasdaq #nyse
To view or add a comment, sign in
79,046 followers